The AIG, Illumina, Alphabet and Orient Life-backed cell therapy developer priced its shares at the bottom of the range to raise $70.6m.

Ping An's financial services spinoff raised $2.36bn in a US initial public offering that represented an exit for Bank of China, Cofco, SBI and several investment banks.

Novo, Bristol Myers-Squibb and Merck Group scored exits as the fibrosis and cancer drug developer priced its shares in the middle of the IPO's range.

Several corporates are set to exit the financial services provider in the biggest IPO in history, while parent company Alibaba will buy about $7.5bn of shares.

The University of Oslo sensor software spinout has started trading on the Merkur Market, part of the Oslo Stock Exchange.

Roche and Novo-backed small molecule therapy developer Aligos Therapeutics has floated in an initial public offering priced in the middle of its range.

Nan Fung-backed hearing aid producer Eargo's shares opened at double its IPO price after it floated above its range.

NTU spinout Nanofilm Technologies has seemingly filed a draft prospectus with a view of listing on the domestic Singapore Stock Exchange.

Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.

The Tencent-backed retail chain floated well above its range in New York and its shares have risen some 40% post-IPO.